| GC38736-50mg |
|
2241300-51-4 |
|
0 |
C16H14Cl2N8O |
|
|
|
| GC38736-10mg |
|
2241300-51-4 |
|
0 |
C16H14Cl2N8O |
|
|
|
| GC38736-5mg |
|
2241300-51-4 |
|
0 |
C16H14Cl2N8O |
|
|
|
| GC38735-10mg |
|
1781934-50-6 |
|
0 |
C19H17ClF2N6O |
|
|
|
| GC38735-5mg |
|
1781934-50-6 |
|
0 |
C19H17ClF2N6O |
|
|
|
| GC38735-1mg |
|
1781934-50-6 |
|
0 |
C19H17ClF2N6O |
|
|
|
| GC38734-5mg |
|
302-91-0 |
|
0 |
C21H34O5 |
|
|
|
| GC38733-5mg |
|
40312-34-3 |
Adenosine A1 receptor activator T62
|
0 |
C15H14ClNOS |
|
|
|
| GC38733-1mg |
|
40312-34-3 |
Adenosine A1 receptor activator T62
|
0 |
C15H14ClNOS |
|
|
|
| GC38732-100mg |
|
773092-05-0 |
Acotiamide monohydrochloride trihydrate
|
0 |
C21H37ClN4O8S |
|
|
|
| GC38732-50mg |
|
773092-05-0 |
Acotiamide monohydrochloride trihydrate
|
0 |
C21H37ClN4O8S |
|
|
|
| GC38732-25mg |
|
773092-05-0 |
Acotiamide monohydrochloride trihydrate
|
0 |
C21H37ClN4O8S |
|
|
|
| GC38732-10mg |
|
773092-05-0 |
Acotiamide monohydrochloride trihydrate
|
0 |
C21H37ClN4O8S |
|
|
|
| GC38732-5mg |
|
773092-05-0 |
Acotiamide monohydrochloride trihydrate
|
0 |
C21H37ClN4O8S |
|
|
|
| GC38731-10mg |
|
— |
2-Furoyl-LIGRLO-amide TFA
|
0 |
C38H64F3N11O10 |
|
|
|
| GC38731-5mg |
|
— |
2-Furoyl-LIGRLO-amide TFA
|
0 |
C38H64F3N11O10 |
|
|
|
| GC38731-1mg |
|
— |
2-Furoyl-LIGRLO-amide TFA
|
0 |
C38H64F3N11O10 |
|
|
|
| GC38730-100mg |
|
2156-29-8 |
|
0 |
C16H19IN2 |
|
|
|
| GC38729-100mg |
|
123-32-0 |
|
0 |
C6H8N2 |
|
|
|
| GC38729-50mg |
|
123-32-0 |
|
0 |
C6H8N2 |
|
|
|
